Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
A new overnight orthokeratology lens called Lunara is now commercially available after receiving FDA premarket approval. Made by X-Cel Specialty Contacts and Essilor Custom Contacts, the lens temporarily corrects myopia of up to 6 diopters while patients sleep. It's designed to fit seamlessly into existing ortho-K practice workflows.
A new overnight orthokeratology (ortho-K) lens called Lunara is now available for eye care providers, following FDA premarket approval (PMA) of its base material, Optimum Infinite (tisilfocon A), earlier this year. Developed by X-Cel Specialty Contacts and Essilor Custom Contacts, the lens is worn overnight to temporarily reshape the cornea and reduce myopia — no daytime glasses or contacts needed.
The lens is designed for patients with myopia up to 6 diopters and astigmatism up to 1.75 diopters, offering a wide range of fitting parameters to accommodate diverse patients. Manufacturers emphasize that the fitting process will feel familiar to any provider who has worked with ortho-K lenses over the past two decades, with dedicated transition support available for practices switching from other systems.
Key Takeaways:
Why it matters: With myopia rates rising globally, FDA-approved overnight correction options give eye care providers a well-regulated, patient-friendly tool — particularly for those seeking alternatives to surgery or daytime lens wear.
